Headquarters:   United States

Destination(s):  

• China
• Greece
• Iraq
• Poland
• Romania

Agencies:  

• Brazil: Administrative Council of Economic Defense (CADE)
• China: Unspecified
• United Kingdom: Serious Fraud Office
• United States: Civil Lawsuit
• United States: Department of Justice
• United States: Securities and Exchange Commission

Entities:  

• Johnson & Johnson ("J&J")
• DePuy, Inc. (Warsaw, Indiana-based wholly-owned medical device subsidiary of J&J) ("DePuy")
• DePuy International Limited (Leeds, UK-based orthopedic subsidiary of DePuy) ("DPI")
• Robert John Dougall (former Director of Marketing at DPI)
• DePuy Helles S.A. (DPI's distributor in Greece; formerly called "DePuy Medec S.A.") ("DePuy Helles")
• Johnson & Johnson Poland Sp. z.o.o. (Poland-based wholly-owned medical device subsidiary of J&J) ("MD&D Poland")
• Janssen-Cilag Eastern Europe (unincorporated organization within J&J that markets pharmaceutical products in southeastern Europe) ("JC-EE")
• Johnson & Johnson d.o.o. (Slovenian limited liability company through which J&J sells pharmaceutical products in Romania) ("Pharma Romania")
• Cilag AG International (wholly-owned pharmaceutical subsidiary of J&J in Switzerland; now known as Cilag GmbH International) ("Cilag")
• Janssen Pharmaceutical N.V. (wholly-owned pharmaceutical subsidiary of J&J in Belgium) ("Janssen")